KLRS vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 13, 2026

KLRS

36.6
AI Score
VS
CBIO Wins

CBIO

68.7
AI Score

Investment Advisor Scores

KLRS

37score
Recommendation
SELL

CBIO

69score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric KLRS CBIO Winner
Revenue 165,000 10.84M CBIO
Net Income -23.84M 153,942 CBIO
Net Margin -14447.9% 1.4% CBIO
Operating Income -26.70M -152.63M KLRS
ROE 46.3% 0.1% KLRS
ROA -17.1% 0.1% CBIO
Total Assets 139.42M 240.29M CBIO
Cash 61.08M 213.19M CBIO
Current Ratio 13.98 6.56 KLRS
Free Cash Flow -20.49M -72.45M KLRS

Relative Price Performance (Last 90 Days)

KLRS 1M: -14.8% · 3M: -51.0% CBIO 1M: +14.3% · 3M: -11.3%

Current Technical Phase

KLRS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -23.5%), weak momentum, RSI 38

RSI (14): 38.5 · Price: $1.90

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.7 · Price: $14.76

Fundamentals Snapshot

Metric KLRS CBIO
Market Cap — —
Forward P/E -1.2 -5.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — 1.0%
Operating Margin 0.0% -14.3%
EPS -1.84 -7.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.